Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Organoneuro Cerebral is a multi-ingredient nutritional supplement developed and marketed by Laboratório Gross in Brazil. It is formulated as coated tablets (dragées) containing a combination of gamma-aminobutyric acid (GABA) tartrate (100 mg), glutamic acid (100 mg), thiamine nitrate (Vitamin B1, 25 mg), pyridoxine hydrochloride (Vitamin B6, 10 mg), and cyanocobalamin (Vitamin B12, 5 mcg). The product is indicated for use in individuals on restrictive or inadequate diets, elderly patients, and those in convalescence from chronic diseases. It serves to support the functioning of the nervous and immune systems by providing essential amino acids and B-complex vitamins that act as metabolic cofactors and neurotransmitter precursors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Organoneuro Cerebral.